Product Information

METHYLPHENIDATE ER(LA) 30 MG CP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.5533 per EA under NDC 75907005101. Its NADAC has been published 94 times since Feb 5, 2025.

FDA first approved this application on Dec 1, 2011. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER(LA) 30 MG CP

Methylphenidate Hydrochloride
$1.5533per EA
DEA Schedule CII

Strength

30 mg/1

NDC

75907005101

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078458

FDA Approved

12/1/2011

TE Code

AB1

On Market Since

12/20/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has been published 94 times since Feb 5, 2025, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5533 per EA
All-time high$2.9289 (Apr 16, 2025)
All-time low$1.5533 (Nov 18, 2026)
52-week high$2.9073
52-week low$1.5533
Median price$2.2328
Average price$2.3306
Largest weekly change+25.9% (Feb 19, 2025)
Weeks tracked94
Tracking sinceFeb 5, 2025

Price History

1W

-9.6%

1M

-18.4%

3M

-23.4%

6M

-25.3%

1Y

-46.6%

3Y

N/A

5Y

N/A

All

-20.8%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER(LA) 30 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 30 MG CP, manufactured by Dr. Reddy's Laboratories Inc., is $1.5533 per EA (NDC 75907005101), effective Nov 18, 2026.

How has the price of METHYLPHENIDATE ER(LA) 30 MG CP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has declined 20.8%. It has been tracked across 94 weekly CMS publications since Feb 5, 2025.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 30 MG CP?

Since Feb 5, 2025, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has ranged from a low of $1.5533 (Nov 18, 2026) to a high of $2.9289 (Apr 16, 2025), with a median of $2.2328 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 30 MG CP?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER(LA) 30 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER(LA) 30 MG CP?

METHYLPHENIDATE ER(LA) 30 MG CP (NDC 75907005101) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.